Downgrades Buy Neutral X

BLCO Bausch + Lomb

Citigroup

$24 $22

Downgrades Overweight Eq-Weight X

BLCO Bausch + Lomb

Morgan Stanley

$19

Upgrades In-line Outperform X

BLCO Bausch + Lomb

Evercore ISI

$19 $25

Initiated Outperform X

BLCO Bausch + Lomb

Raymond James

$19

Downgrades Outperform In-line X

BLCO Bausch + Lomb

Evercore ISI

$19 $17

Initiated Hold X

BLCO Bausch + Lomb

Stifel

$16

Resumed Outperform X

BLCO Bausch + Lomb

Evercore ISI

$20

Resumed Equal-Weight X

BLCO Bausch + Lomb

Morgan Stanley

$20

Initiated Hold X

BLCO Bausch + Lomb

Needham

Initiated Equal Weight X

BLCO Bausch + Lomb

Barclays

$17

Initiated Buy X

BLCO Bausch + Lomb

H.C. Wainwright

$21

Initiated Outperform X

BLCO Bausch + Lomb

RBC Capital Mkts

$22

Initiated Outperform X

BLCO Bausch + Lomb

Evercore ISI

$21

Initiated Buy X

BLCO Bausch + Lomb

Citigroup

Initiated Hold X

BLCO Bausch + Lomb

Deutsche Bank

$19

Initiated Neutral X

BLCO Bausch + Lomb

Goldman

$22

Initiated Buy X

BLCO Bausch + Lomb

Guggenheim

$24

Initiated Buy X

BLCO Bausch + Lomb

Jefferies

$25

Initiated Neutral X

BLCO Bausch + Lomb

JP Morgan

$20

Initiated Equal-Weight X

BLCO Bausch + Lomb

Morgan Stanley

$22

Initiated Overweight X

BLCO Bausch + Lomb

Wells Fargo

$23

Initiated Outperform X

BLCO Bausch + Lomb

Cowen

$35

BLCO  Bausch + Lomb Corporation

Bausch + Lomb Corporation operates as an eye health company. The Company offers eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, and ophthalmic surgical devices and instruments. Bausch + Lomb serves customers worldwide.